With EU CE mark clearance for LigaSure RAS, Medtronic expands the Hugo system’s capabilities in gynaecologic and urologic ...

Medtronic announced today that it received CE mark for its LigaSure vessel sealing technology for use with its Hugo system.

Medtronic said its market-leading LigaSure technology can now be used with its Hugo soft tissue robotic surgery system in ...

Medtronic has announced the first subject enrolment in the Peripheral Onyx Liquid Embolic (PELE) trial. The study aims to ...

Medtronic surgical robotics head talks Hugo, taking on Intuitive, COVID-19 challenges Megan Rosengarten discusses challenging Intuitive Surgical's 20-year lead in soft tissue robotics, growing ...

DUBLIN, July 29, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first gynecological (GYN) procedures with the Hugo™ robotic-assisted ...

Medtronic's long-term dividend streak also points to a business capable of performing well over long periods. Healthcare ...

Medtronic CEO Geoff Martha has a simple message for the skeptics: despite some bumps in the road, the robots are coming. “We expect Hugo to deliver double digit millions in sales this fiscal ...

Medtronic is a diversified medical device company with a low-growth value stock position. The Hugo RAS system has the potential to drive significant growth for Medtronic in the robotic-assisted ...

Medtronic plc MDT recently announced the integration of its Hugo robotic-assisted surgery (RAS) system at Hospital Clinico de la Red de Salud UC CHRISTUS in Santiago, Chile, to support the ...

Hugo is already on the market in some countries, but made a slow start commercially. Medtronic cut its sales forecast in 2021, slashing the midpoint of its range from $75 million to $30 million ...

The "Hugo" name is trademarked. Medtronic's robotics system has been in use for less than a year. It was first used on a patient seven months ago, ...